High Throughput Screening Identifies Molecules That Reduce Cellular Stress

The technique could help researchers find drugs that improve health and lengthen life.

11:12 AM

Author | Kelly Malcom

yellow sand clock on dark blue background
Illustration: Stephanie King

For many, getting older can unfortunately mean an increased risk of illness from cardiovascular disease to cancer. University of Michigan scientists are actively researching the biological underpinnings of aging with the aim of developing interventions that could potentially help people live longer, healthier lives.

A new paper in the journal Science Advances describes the discovery of several promising small molecules that appear to reduce cellular stress in mouse skin cells and could lengthen life.

"Cellular stress resistance appears to be a common feature of long-lived organisms, such as invertebrates and mice," says the paper's lead author David Lombard, M.D., Ph.D., associate professor of pathology. Lombard is part of a multidisciplinary group at U-M's Paul F. Glenn Center for Aging. Recent research from colleague and fellow study author Richard Miller, M.D., Ph.D., found several promising drugs, including rapamycin, a cancer drug, and acarbose, a diabetes drug, that extended life in mice.

The new study, which uses high throughput screening, a technique that allows for the examination of hundreds of compounds at once, gets around some of the limitations posed by mouse studies.

"Mice live on average three years, which makes using them for longevity studies time-consuming and expensive," Lombard explains. By using cells to examine how a cell responds to stress, they hope to develop a proxy system with which to look at aging.

For the study, mouse skin cells were exposed to three types of environmental stress: a toxic herbicide called paraquat, the heavy metal cadmium and methyl methansulfonate, which damages DNA. After treatment with more than 4500 compounds, the team identified hundreds of small molecules that conferred some degree of protection against one or more of the stressors. The team then focused on eight compounds for a closer examination of how they worked at the molecular level.

Lombard explains that two candidates, AEG 3482 and cardamonin (found in spices such as cardamom), appeared to activate the Nrf2/SKN-1 pathway. Previous research has shown that this pathway helps cells resist stress and is implicated in the life-lengthening effects of several other interventions in C. elegans, a worm frequently used for aging studies, and can even extend the lifespan of male mice.

MORE FROM THE LAB: Subscribe to our weekly newsletter

Comparing their findings to a different study of longevity in C. elegans, they found some of the same compounds that protected worms from stress were of the same class as those that their team identified as effective in mouse cells.

The team notes that their method has limitations. For example, they found that rapamycin and acarbose, previously shown to extend life in mice, did not protect against the stressors they used. And, says Lombard, a lot more work needs to occur before the findings can be extrapolated to humans. "I think the bottom line is we're fairly different than worms and flies, and some of these drugs have similar effects in different organisms, but it's not a one to one relationship."

Lombard says the promise of the method is its ability to find interesting drugs for follow up, especially to study their mechanism of action. "I don't think any are ready for lifespan studies, but what we've identified is an interesting group of compounds that have some intriguing effects in cells and in invertebrates."

Paper cited: "High-throughput small-molecule screening reveals Nrf2-dependent and -independent pathways of cellular stress resistance," Science AdvancesDOI: 10.1126/sciadv.aaz7628


More Articles About: Lab Report Basic Science and Laboratory Research Geriatrics Drug Discovery All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories man in pink shirt close up with hand on stomach
Health Lab
Potential culprit identified in lingering Crohn’s disease symptoms
A study from University of Michigan researchers may explain why some patients with Crohn’s disease continue to experience symptoms, even in the absence of inflammation.
surgical area of clinicians drawn out with blue background
Health Lab
New tools that leverage NIH’s ‘All of Us’ dataset could improve anesthesia and surgical care
In a report in JAMA Surgery, researchers propose two novel tools that leverage the All of Us dataset to look at acute health events such as surgery.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory
The Link Between Hearing Loss and Cognitive Decline
Hearing loss is one of the most common conditions of aging, affecting nearly two-thirds of older adults over the age of 70, but it’s not just a matter of diminished hearing. Hearing loss can contribute to poor psychosocial outcomes for patients including loneliness, depression, and social isolation. New research also shows that hearing loss is linked to a higher risk of cognitive decline and dementia. In fact, the 2024 Lancet Commission on Dementia Prevention, Intervention, and Care identified hearing loss as one of 14 modifiable risk factors for dementia. According to the commission, treating hearing loss could prevent up to 7% of dementia cases globally, making it one of the most impactful areas for potential prevention. This raises the question of whether use of hearing aids in people with hearing loss can reduce or mitigate this increased dementia risk. To help us understand these connections and the latest research in this area, we are joined today by Dr. Alison Huang, an epidemiologist and Senior Research Associate from the Johns Hopkins Cochlear Center for Hearing and Public Health. Her research studies the impact of sensory loss on cognitive and mental health in older adults. Dr. Huang was an author of the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study, a large, multicenter randomized controlled trial that tested whether treating hearing loss in older adults could help slow cognitive decline published in the Lancet. Alison Huang, PhD, MPH Link to article: Lin FR, Pike JR, Albert MS, Arnold M, Burgard S, Chisolm T, Couper D, Deal JA, Goman AM, Glynn NW, Gmelin T, Gravens-Mueller L, Hayden KM, Huang AR, Knopman D, Mitchell CM, Mosley T, Pankow JS, Reed NS, Sanchez V, Schrack JA, Windham BG, Coresh J; ACHIEVE Collaborative Research Group. Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial. Lancet. 2023 Sep 2;402(10404):786-797. doi: 10.1016/S0140-6736(23)01406-X. Epub 2023 Jul 18. PMID: 37478886; PMCID: PMC10529382.
friends talking outside older walking smiling
Health Lab
Older adults’ health may get a little help from their friends 
Close friendships include help with health-related advice or support for people over 50, but those with major mental or physical health issues have fewer close friends.
navy brain on off white background with artificial intelligence lines inside with yellow highlighted areas
Health Lab
People want to know if AI is used in their health care
A study published in JAMA Network Open finds most people want to be notified if AI is used in their health care.
PURPLE BLUE RED CELLS FLOATING
Health Lab
Using cellular therapy to treat cancer, and beyond
Here, Monalisa Ghosh, M.D., a hematologist-oncologist at the University of Michigan Health Rogel Cancer Center, answers questions about cellular therapy; how it's used and what exciting developments are soon to come.